How Sugar and Sedentary Lifestyle Affects Men
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard
Good sleep isn’t just about feeling rested — it’s vital for cardiovascular health. Research shows that poor sleep patterns can increase the risk of high blood pressure, heart disease, and even stroke. For healthcare professionals, whose shifts often disrupt sleep, the risks are even higher. When the body doesn’t get enough rest, stress hormones like…
The FreeStyle Libre system from Abbott is a groundbreaking continuous (or “flash”) glucose monitoring device that allows users to track their glucose levels throughout the day without the routine of fingerstick testing. The wearable sensor—applied to the back of the upper arm—measures interstitial glucose every minute and stores data in 15-minute intervals, which can be…
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard
The pharmaceutical industry is undergoing a transformation, and biomarkers are at the center of this change. Biomarkers — measurable indicators like proteins, genes, or metabolic changes — allow researchers to better predict how patients will respond to treatments. By using biomarkers in drug development, companies can design more targeted therapies, improve clinical trial efficiency, and…
In a striking move toward collaborative innovation, Bristol Myers Squibb, Takeda, AbbVie, and Johnson & Johnson have joined forces through a shared data consortium to advance AI-enabled drug discovery. Their objective is to pool proprietary protein-small molecule datasets via a federated learning framework, enabling secure contributions without exposing sensitive information. This collective approach aims to…